RecruitingNCT06059313

Premorbid Personality Profile of Patients With Cognitive and Behavioral Disorders

Relationship Between Premorbid Personality Traits and Cognitive and Behavioral Disorders


Sponsor

Nantes University Hospital

Enrollment

120 participants

Start Date

Dec 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Damages in frontal area present in neurodegenerative disease (frontotemporal degeneration, frontal variant of Alzheimer disease) and in psychiatric disease (bipolar disorder) can affect behavior and cognition including social cognition. Symptoms vary both quantitatively and qualitatively from disease to another and from person to person. It cannot be completely excluded that in some cases, factors of susceptibility such as premorbid personality traits lead to frontal fragility. The study will assess the relationship between premorbid profile using NEO-PI 3 inventory and cognitive and behavioral/psychobehavioral manifestations in patients with behavioral variant of frontotemporal disorder (bvFTD), phenocopy frontotemporal dementia (phFTD), frontal variant of Alzheimer disease, bipolar disorder characterized with frontal damages.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Submission of the Interpersonal Reactivity Index questionnaire (IRI) and Submission of the NEO-PI-3 questionnaire for people with behavioral variant of frontotemporal disorder (bvftd), bipolar disorder, and other related conditions. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSubmission of the NEO-PI-3 questionnaire

The questionnaire contains 240 statements. For each statement, the patient chooses the answer that best corresponds to their choice (FD: strongly disagree - D: disagree - N: neutral - A: agree - FA: strongly agree).

OTHERSubmission of the Interpersonal Reactivity Index questionnaire (IRI)

The test assesses two cognitive and two affective components of empathy that influence each other and affect attitudes and behaviors toward others.


Locations(1)

CHU de Nantes

Nantes, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06059313


Related Trials